Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence.
about
NMR characterization of the interaction between the C-terminal domain of interferon-gamma and heparin-derived oligosaccharidesHuman immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionThe T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chainsBenzylpenicillin differentially conjugates to IFN-gamma, TNF-alpha, IL-1beta, IL-4 and IL-13 but selectively reduces IFN-gamma activity.Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.Hijacking of the pleiotropic cytokine interferon-γ by the type III secretion system of Yersinia pestisModulation of Interleukin-12 activity in the presence of heparinMolecular and cellular immune responses to ischemic brain injuryVarious forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.On-line capillary isoelectric focusing hyphenated to native electrospray ionization mass spectrometry for the characterization of interferon-γ and variants.Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules.The agouti-related peptide binds heparan sulfate through segments critical for its orexigenic effects.Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infectionCytokine-receptor interactions as drug targets.The proteoglycan glycomatrix: a sugar microenvironment essential for complement regulation.Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon-gamma inhibits the cytokine activity.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Sulfated glycopeptide nanostructures for multipotent protein activation.Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice.More than a biomarker: the systemic consequences of heparan sulfate fragments released during endothelial surface layer degradation (2017 Grover Conference Series).Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses.Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.Acidic pH modulates the interaction between human granulocyte-macrophage colony-stimulating factor and glycosaminoglycans.Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides.The Heparan Sulfate Binding Sequence of Interferon-γ Increased the On Rate of the Interferon-γ-Interferon-γ Receptor Complex FormationThe localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit
P2860
Q24528129-0BC3CE6C-916F-46B6-B63A-2CF19B804A16Q27004059-DAB8E71F-44E2-4952-9732-419C48F40460Q28265025-5B828228-1A93-4083-BF96-433911C334CAQ30332462-D400BCC6-052D-40E3-A2D2-006A150BB77BQ33722207-3B9C9223-9969-4C56-B193-0DE11441B06AQ33778441-F97F1A95-39E7-4374-B404-A48FE9EE08C4Q33903041-FA4C5FB0-6F9B-430E-957C-E36673937F79Q34016804-8D933F16-F3A0-49BB-882C-FD76FF142627Q35022269-BCAFAD5E-EFFA-4A37-985A-3744A84CDAF4Q35216404-E330FA79-7A78-43FD-A2CD-D0FD2C9EABB3Q35435634-FED12FCB-E518-4871-B085-622C34A56ABAQ35580817-2108DE8E-6F94-4FF9-93BA-B4AE5CCD1047Q36298889-3BD2F052-C81E-4AB4-830B-5F442D9A3F5CQ37760881-1F2C1C82-6D19-4792-9313-B634BED20B7EQ37771522-053E2599-EE4E-4132-82E9-6245E4712C8EQ38170110-454DD4A2-69CD-4490-86FF-367A979B57CCQ38321196-9B49CE52-3A70-4D0A-906E-86BAEEBD2CE6Q38418286-80275BF3-81A0-4226-BA40-AEED9CFFA51EQ38666664-AED7E79E-9EEF-495C-83BD-433B4CBADA13Q45874899-535789DC-CDD7-40A3-A0A0-9402B9471F57Q47143359-9F54D79B-EB53-48E4-92AE-3949D6D706BDQ47271943-33567B86-A12A-460E-9F20-94BE3FD487E4Q47719302-7BCEB6A3-DA4E-4448-B510-4D1DBD4B452CQ50516176-2E07B199-6772-419A-B8F9-AA2A0E961402Q53986493-7D0ECC86-7065-409B-B518-5D8A678B88D5Q56551910-C723A754-3EFC-4FD0-9006-99A566828F03Q58794936-FB1D1FEF-369C-49B0-9DDC-06D4B22DA4E7
P2860
Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Heparin decreases the blood cl ...... ts carboxyl-terminal sequence.
@en
type
label
Heparin decreases the blood cl ...... ts carboxyl-terminal sequence.
@en
prefLabel
Heparin decreases the blood cl ...... ts carboxyl-terminal sequence.
@en
P2093
P2860
P356
P1476
Heparin decreases the blood cl ...... ts carboxyl-terminal sequence.
@en
P2093
Grimaud JA
Lortat-Jacob H
P2860
P304
16139-16143
P356
10.1074/JBC.271.27.16139
P407
P577
1996-07-01T00:00:00Z